Do skip-N2 metastases significantly impact overall survival and disease-free interval in N2 non-small-cell lung cancer patients? A multicentre analysis.
Schlachtenberger G, Schallenberg S, Doerr F, Menghesha H, Gaisendrees C, Amorin A, Grathwohl C, Büttner R, Quaas A, Horst D, Klauschen F, Frost N, Rueckert JC, Neudecker J, Höpker K, Wahlers T, Hekmat K, Heldwein MB.
Schlachtenberger G, et al.
Eur J Cardiothorac Surg. 2023 Jul 3;64(1):ezad247. doi: 10.1093/ejcts/ezad247.
Eur J Cardiothorac Surg. 2023.
PMID: 37369037